BCDA
Price:
$1.47
Market Cap:
$8.52M
BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary disease. The company is also developing allogeneic cells therapeutic platform, an investigational culture expanded bone marrow derived mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic systolic heart failure. In addition, it offers the Helix biotherapeutic delivery system that delivers therapeutics into the heart muscl...[Read more]
Industry
Biotechnology
IPO Date
1996-11-13
Stock Exchange
NASDAQ
Ticker
BCDA
According to BioCardia, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 3.88M. This represents a change of -99.81% compared to the average of 2.03B of the last 4 quarters.
The mean historical Enterprise Value of BioCardia, Inc. over the last ten years is 104.34M. The current 3.88M Enterprise Value has changed 271.42% with respect to the historical average. Over the past ten years (40 quarters), BCDA's Enterprise Value was at its highest in in the September 2025 quarter at 8.09B. The Enterprise Value was at its lowest in in the March 2016 quarter at -8807064.32.
Average
104.34M
Median
85.85M
Minimum
-3672515.90
Maximum
304.14M
Discovering the peaks and valleys of BioCardia, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 45.56%
Maximum Annual Enterprise Value = 304.14M
Minimum Annual Increase = -8381.39%
Minimum Annual Enterprise Value = -3672515.90
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 4.56M | -68.04% |
| 2023 | 14.28M | -86.45% |
| 2022 | 105.34M | 20.43% |
| 2021 | 87.47M | 3.84% |
| 2020 | 84.24M | 45.56% |
| 2019 | 57.87M | -56.42% |
| 2018 | 132.80M | -48.19% |
| 2017 | 256.34M | -15.71% |
| 2016 | 304.14M | -8381.39% |
| 2015 | -3672515.90 | -4052.15% |
The current Enterprise Value of BioCardia, Inc. (BCDA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
41.39M
5-year avg
59.18M
10-year avg
104.34M
BioCardia, Inc.’s Enterprise Value is greater than Creative Medical Technology Holdings, Inc. (-815059.00), greater than Aprea Therapeutics, Inc. (-10063033.00), greater than Acurx Pharmaceuticals, Inc. (-5901286277.00), less than Kiora Pharmaceuticals, Inc. (7.29M), less than HCW Biologics Inc. (10.10M), greater than Alzamend Neuro, Inc. (1.13M), greater than Adial Pharmaceuticals, Inc. (3.22M), greater than IN8bio, Inc. (702.60K), greater than Phio Pharmaceuticals Corp. (3.83M), less than Aptevo Therapeutics Inc. (66.93M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| -815059.00 | $5.73M | |
| -10063033.00 | $6.47M | |
| -5901286277.00 | $5.52M | |
| 7.29M | $7.89M | |
| 10.10M | $4.39M | |
| 1.13M | $6.75M | |
| 3.22M | $7.82M | |
| 702.60K | $8.43M | |
| 3.83M | $14.53M | |
| 66.93M | $41.10M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioCardia, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BioCardia, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is BioCardia, Inc.'s Enterprise Value?
What is the highest Enterprise Value for BioCardia, Inc. (BCDA)?
What is the 3-year average Enterprise Value for BioCardia, Inc. (BCDA)?
What is the 5-year average Enterprise Value for BioCardia, Inc. (BCDA)?
How does the current Enterprise Value for BioCardia, Inc. (BCDA) compare to its historical average?